Related Experiment Video
Updated: Aug 15, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
The bcl-2 gene product prevents programmed cell death of ventricular myocytes
L A Kirshenbaum1, D de Moissac
1Institute of Cardiovascular Sciences, St Boniface General Hospital Research Centre, Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada. Lorrie@SBRC.umanitoba.ca
Background:
To formally test whether the antiapoptotic protein bcl-2 would prevent programmed cell death in cardiac muscle cells provoked by p53, a known trigger of apoptosis in a variety of different cell types, we used replication defective adenovirus encoding either the bcl-2 and p53 genes to deliver bcl-2 and p53 to ventricular myocytes with high efficiency and uniformity.
Methods And Results:
Vital staining of ventricular myocytes revealed a significant (7-fold, P<.05) increase in myocyte cell death in the presence of p53 in contrast to uninfected cells or those infected with a control virus. In addition, in the presence of p53, nucleosomal DNA fragmentation observed by Hoescht 33258 staining and terminal transferase deoxynucleotide end labeling indicated a significant increase in apoptotic cardiac nuclei compared with control cells, confirming the hypothesis that p53 alone is sufficient to trigger apoptosis of ventricular myocytes. Moreover, a significant increase in transcription of the bax promoter was seen in the presence but not in the absence of p53 compared with control cells. Expression of the antiapoptotic gene bcl-2 in ventricular myocytes was sufficient to prevent ventricular myocyte death and apoptosis provoked by p53. Importantly, the antiapoptotic effects of bcl-2 were independent of altered p53 expression or localization of p53 to cardiac nuclei. However, p53 dependent transcription of bax was repressed 4-fold (P<.05) by bcl-2, suggesting a tentative link between p53-mediated apoptosis and the protective properties conferred by bcl-2 in ventricular myocytes.
Conclusions:
To our knowledge, the data provide the first indication for the operation of bcl-2 in ventricular myocytes as an antiapoptotic factor.
Insights
The antiapoptotic protein bcl-2 prevents programmed cell death in cardiac muscle cells triggered by p53. This study demonstrates bcl-2
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- Cell Death Research
Background:
- Programmed cell death (apoptosis) is crucial in cardiac muscle.
- p53 is a known inducer of apoptosis across various cell types.
- The role of bcl-2 in preventing cardiac myocyte apoptosis requires investigation.
Purpose of the Study:
- To determine if the antiapoptotic protein bcl-2 can prevent p53-induced apoptosis in cardiac muscle cells (ventricular myocytes).
Main Methods:
- Utilized replication-defective adenovirus to deliver bcl-2 and p53 genes into ventricular myocytes.
- Assessed myocyte cell death using vital staining.
- Evaluated apoptosis via DNA fragmentation and terminal transferase deoxynucleotide end labeling.
- Measured bax promoter transcription levels.
Main Results:
- p53 significantly increased ventricular myocyte death and apoptosis.
- p53 also increased bax promoter transcription.
- bcl-2 expression prevented p53-induced myocyte death and apoptosis.
- bcl-2 repressed p53-dependent bax transcription.
Conclusions:
- bcl-2 functions as an antiapoptotic factor in ventricular myocytes.
- This is the first evidence of bcl-2's antiapoptotic role in cardiac muscle cells.
- bcl-2's protective effect is linked to the repression of p53-mediated bax transcription.
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy

